15.4
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the c…
Mitral regurgitation, or MR, is a heart condition where the mitral valve fails to close entirely during systole, causing blood to leak backward from the left ventricle into the left atrium.
Its etiology is classified into two types.
Primary MR originates from direct mitral valve abnormalities, including mitral valve prolapse, rheumatic fever, and degenerative changes.
Secondary MR results from indirect factors like ischemic heart disease and infective endocarditis.
The pathophysiology of MR involves dysfunction in the mitral valve or its supporting structures, including the leaflets, chordae tendineae, annulus, or papillary muscles, which leads to backward blood flow and volume overload.
This overload causes left atrial enlargement and left ventricular hypertrophy and dilation.
These compensatory changes can eventually result in systolic dysfunction.
Increased pressure in the left atrium may cause pulmonary congestion and hypertension, straining the right ventricle and leading to reduced cardiac output and heart failure symptoms.
View the full transcript and gain access to JoVE Core videos
Q1: What happens to blood flow when the mitral valve fails to close properly?
When the mitral valve fails to close entirely during systole, blood leaks backward from the left ventricle into the left atrium instead of being pumped forward. This abnormal backward circulation reduces the efficiency of cardiac output and forces the heart to work harder to maintain adequate blood flow throughout the body.
Q2: What are the two main categories of mitral regurgitation causes?
Primary mitral regurgitation originates from direct valve abnormalities such as mitral valve prolapse, rheumatic fever, and degenerative changes affecting the leaflets and chordae tendineae. Secondary mitral regurgitation results from indirect factors like ischemic heart disease, myocardial infarction, and infective endocarditis that damage supporting structures or alter ventricular geometry.
Q3: How does mitral regurgitation affect the structure of the heart chambers?
The regurgitated blood creates volume overload in the left atrium and ventricle, causing them to enlarge and stretch. Initially, this adaptive response of hypertrophy and dilation helps maintain cardiac output, but chronic volume overload eventually leads to progressive ventricular dilation and systolic dysfunction.
Q4: What role do the mitral valve's supporting structures play in regurgitation?
The mitral valve's supporting structures include the leaflets, chordae tendineae, annulus, and papillary muscles. Dysfunction or damage to any of these components prevents complete valve closure during systole, leading to incomplete valve closure and blood regurgitation into the left atrium.
Q5: How does increased pressure in the left atrium affect the lungs and right heart?
Increased pressure in the left atrium due to regurgitated blood leads to pulmonary congestion and pulmonary hypertension. This back pressure strains the right ventricle, potentially causing right-sided heart failure and reducing overall cardiac output, which manifests as fatigue and exertional dyspnea.
Q6: What is the relationship between chronic mitral regurgitation and heart failure?
Chronic volume overload and increased atrial pressures result in progressive ventricular dilation and dysfunction, culminating in systolic heart failure. The heart's pumping efficiency decreases over time, reducing cardiac output and causing symptoms such as reduced exercise tolerance and breathing difficulties.
Q7: How do rheumatic fever and degenerative changes cause primary mitral regurgitation?
Rheumatic fever causes scarring and deformation of the mitral valve leaflets, while degenerative changes cause the leaflets and chordae tendineae to thicken and become fibrotic. Both conditions impair the valve's ability to close completely, resulting in blood leakage during systole.